NCT02437981

Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic

Thai Red Cross AIDS Research Centre (TRC-ARC)

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 20,000 (estimated)
• Sponsor: Thai Red Cross AIDS Research Centre · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

PrEP-30 is a demonstration project to assess the feasibility of providing oral PrEP to MSM and other individuals at-risk for HIV in Bangkok, Thailand as a service that is funded entirely through user fees. Tenofovir disoproxil fumarate/emtricitabine PrEP is provided part of a combined HIV prevention program that includes risk-reduction counseling, regular HIV testing, and the provision of condoms and lubricants. PrEP-30 is implemented at the Thai Red Cross AIDS Research Centre, at the site of the largest HIV counseling and testing center in Thailand.

Conditions

• HIV Prevention

Interventions

Type	Name	Description
DRUG	PrEP	Oral pre-exposure prophylaxis (PrEP) for HIV infection using a daily combination tablet of tenofovir disoproxil fumarate and emtricitabine

Timeline

• Start date: 2014-12-01
• Primary completion: 2024-12-01
• Completion: 2027-01-01
• First posted: 2015-05-08
• Last updated: 2024-11-25

Locations

1 site across 1 country: Thailand